We have received several inquiries from clients asking for
guidance regarding their shareholders meetings in light of the
rapidly evolving novel coronavirus
("COVID-19") pandemic and the need to
socially distance ourselves. With the annual general shareholder
meeting ("AGM") season upon us, this
article seeks to provide information relating to (i) the options
available for holding AGMs in light of the COVID-19 concerns and
(ii) the procedures to be followed in the event that an issuer
decides to change the date, time or location of its in person AGM
due to COVID-19.
We note that the discussion in this article relates to business
transacted at AGMs (for example, election of directors and
amendments to equity incentive plans). Issuers involved in proxy
contests, holding special meetings for merger and acquisition
transactions, or obtaining securityholder approval for transactions
under Multilateral Instrument 61-101 Protection of Minority
Securityholders in Special